JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

602 * Thu, 8/2/2012, 8:30 AM - 10:20 AM CC-Room 21
Recent Developments in Bayesian Evidence Synthesis with Applications in Health Technology Evaluation and Comparative Effectiveness — Topic Contributed Papers
Biopharmaceutical Section , International Indian Statistical Association
Organizer(s): David I Ohlssen, Novartis
Chair(s): Karen Price, Eli Lilly and Company
8:35 AM Statistical Approaches for Conducting Network Meta-Analysis in Drug Development Byron Jones, Novartis Pharma AG
8:55 AM Use of Bayesian Meta-Analysis Methods to Develop a Tool to Predict the Risk of Stent Thrombosis (ST) Following the Implantation of a Coronary Artery Stent Mark Belger, Eli Lilly and Company ; Fanni Natanegara, Eli Lilly and Company ; Ming-Dauh Wang, Eli Lilly and Company ; Walid Fakhouri, Eli Lilly and Company ; Peita Graham-Clarke, Eli Lilly and Company
9:15 AM A Bayesian Approach to Three Levels Surrogacy Modeling for Multiple Sclerosis Luca Pozzi, University of California at Berkeley ; David I Ohlssen, Novartis ; Heinz Schmidli, Novartis Pharma AG
9:35 AM Application of Bayesian Nonparametric Models in Comparative Effectiveness Research Gary Rosner, The Johns Hopkins University
9:55 AM Discussant: Greg (Guoxing) Soon, FDA
10:15 AM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.